Kathryn E. Stephenson
Advanced in Chikungunya

Dr. Kathryn E. Stephenson

Internal Medicine
330 Brookline Avenue, E-cls 1047, 
Boston, MA 
On Staff At
Advanced in Chikungunya
330 Brookline Avenue, E-cls 1047, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kathryn Stephenson is an Internal Medicine provider in Boston, Massachusetts. Dr. Stephenson is rated as an Advanced provider by MediFind in the treatment of Chikungunya. Her top areas of expertise are HIV/AIDS, Togaviridae Disease, Chikungunya, and Severe Acute Respiratory Syndrome (SARS).

Her clinical research consists of co-authoring 71 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Chikungunya.

Graduate Institution
New York University School Of Medicine
Residency
New York Presbyterian Hospital (Columbia Campus)
Specialties
Internal Medicine
Licenses
Internal Medicine in NY
Board Certifications
American Board Of Internal Medicine
Fellowships
Massachusetts General Hospital
Hospital Affiliations
Beth Israel Deaconess Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Senior Whole Health
  • MEDICARE-MEDICAID PLAN
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

BIDMC - Center for Virology and Vaccine Research
330 Brookline Avenue, E-cls 1047, Boston, MA 02215

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
Enrollment Status: Terminated
Publish Date: October 17, 2025
Intervention Type: Drug
Study Drug: Casirivimab+Imdevimab
Study Phase: Phase 3
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Enrollment Status: Completed
Publish Date: September 25, 2023
Intervention Type: Drug
Study Drugs: Infliximab, Abatacept, Remdesivir, Cenicriviroc
Study Phase: Phase 3
A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an Accelerated Vaccination Schedule With a Zika Virus Purified Inactivated Vaccine Plus Alum Adjuvant in Healthy Adults
A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an Accelerated Vaccination Schedule With a Zika Virus Purified Inactivated Vaccine Plus Alum Adjuvant in Healthy Adults
Enrollment Status: Completed
Publish Date: August 23, 2018
Intervention Type: Other, Biological
Study Phase: Phase 1
View 2 Less Clinical Trials

71 Total Publications

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.
Journal: Science translational medicine
Published: July 30, 2025
Similar Doctors
Advanced in Chikungunya
Dr. Farah Deeba
Internal Medicine
Advanced in Chikungunya
Dr. Farah Deeba
Internal Medicine

Lahey Clinic Inc

298 Washington St, Addison Gilbert, 
Gloucester, MA 
 (29.2 miles away)
978-283-4000
Languages Spoken:
English
See accepted insurances

Farah Deeba is a primary care provider, practicing in Internal Medicine in Gloucester, Massachusetts. Dr. Deeba is rated as an Advanced provider by MediFind in the treatment of Chikungunya. Her top areas of expertise are Fainting, Familial Neurocardiogenic Syncope, Cellulitis, Endoscopy, and Ureteroscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stephenson's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile